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Olfactory disorders are not as rare as you might think: estimates are that 1-5% of the 
population experience it at some point in their lives1. It can happen as a result of chronic 
sinusitis, damage caused by cold viruses, or even a head injury. It is sometimes also a 
precursor of nervous system diseases such as Parkinson’s and Alzheimer’s. But compared 
with hearing and sight loss, it receives little research or medical attention. Losing any sensory 
input should not be underestimated, this is an argument best reasoned by those who have 
suffered this loss. 
A recent qualitative study by Erskine and Philpott2 provided an opportunity to better 
understand the issues people with smell disorders face. Through the analysis of written, 
personal accounts of anosmia (loss of sense of smell) sent in to the Norfolk Smell & Taste 
Clinic by 71 sufferers, the texts revealed several themes, including feelings of isolation, 
relationship difficulties, impact on physical health and also the difficulty and cost of seeking 
help. Many people also commented on the negative attitude from doctors about smell loss, 
and how they found it difficult to get advice and treatment for their condition. 
Significant harm 
Smell loss leaves sufferers vulnerable to environmental hazards, such as spoiled food and gas 
leaks. It also has a negative effect on a range of activities and experiences, potentially causing 
significant harm. In reality, perhaps this is not surprising given the extra dimension that smell 
gives to the enjoyment of food, exploration of our environment and bringing back memories. 
So, our sense of smell is both a life-saving and life-enhancing sense. Losing it can have the 
opposite effect. Indeed, there is now accumulating evidence that recent studies from the 
US and Scandinavia show that anosmia is an independent risk factor for advanced mortality, 
even when other neurocognitive and cardiovascular factors are controlled for3 4. Perhaps, 
given the relative exposure of the olfactory apparatus to the external world through the 
“unprotected” olfactory neuroepithelium, smell loss acts as a marker for overall neural 
toxicity. It may therefore be that in future, screening through smell may facilitate health and 
lifestyle guidance and prognosis. 
What it’s like to live without a sense of smell 
The aforementioned qualitative study confirmed previous survey findings from 20145 that 
showed that anosmia led to physical concerns included diet and appetite. Because of the 
reduced pleasure of eating, some participants reported a reduced appetite with subsequent 
weight loss. Others reported a general decline in the quality of their diet with the reduced 
perception of flavours leading to an increased intake of foods with low nutritional value 
(particularly those high in fat, salt and sugar). Many anosmia sufferers complain of a loss of 
taste as part of their disorder, when in reality they can taste without impairment but have 
loss the process of retronasal olfaction that occurs during eating. Salt, sweet, sour, bitter and 
umami are the sensations detected via the taste buds on the tongue and other parts of the 
mouth and throat; but smell accounts for our 80% of all flavour perception and as ordinarily, 
the two sensations coincide, most sufferers assume both sensory modalities have been 
affected. True gustatory loss accounts for about 1% of the total workload of a Smell & Taste 
clinic, such as the one established at the James Paget University Hospital in Gorleston, 
Norfolk6. 
Emotional disruption 
Emotional negatives experienced by sufferers include embarrassment, sadness, depression, 
worry and bereavement. The study by Erskine and Philpott showed evidence that it disrupted 
every aspect of life. These ranged from everyday concerns, such as personal hygiene, to loss 
of intimacy and the breakdown of personal relationships. Some participants reported that 
they couldn’t take pleasure in occasions that would usually be a cause for celebration. The 
inability to link smells with happy memories may render these events underwhelming 
experiences.  
Underlying these emotions was the loss of enjoyment of activities, difficulty in expressing the 
impact of symptoms of anosmia and little sympathy or understanding from outsiders. Others 
included reduced socialising, no effective treatments and little hope of recovery. Many 
participants described a profound effect on their relationships with other people as a result 
of their smell disorder. These range from not enjoying eating together to more intimate 
relationships - particularly sex.  
The financial burdens described included the cost of private referral and alternative 
treatments. The effects were profound for some, especially if their profession or safety 
depends upon it. Participants often described negative or unhelpful interactions with GPs and 
specialists, such as ear, nose and throat surgeons. Participants were concerned by a lack of 
empathy. Unlike spectacles or hearing aids, no simple solutions are yet available for smell 
loss. The subject of smell loss remains an enigma to many medical students and doctors, with 
little training provided on the subject to facilitate appropriate knowledge. Coupled with a 
relative paucity of known effective treatments for smell loss, this accounts for the relative 
apathy of the medical profession in comparison to other sensory losses. Study participants 
and clinic attendees frequently report being told by clinicians that they should consider that 
their position could be far worse because they could have lost another sense instead! 
 
Support is at hand 
This article will not explore management and treatment of olfactory disorders – this can be 
found elsewhere7-9. However, a key advance in the last decade has been the initiation of a 
charity to support sufferers of smell and taste disorders. Fifth Sense was established in 2012 
by Duncan Boak, an anosmia sufferer and has grown to the point where in 2018 the charity 
received formal registration from the Charities Commission and most recently secured 
Lottery Funding support. This latest opportunity will enable Fifth Sense to begin to establish 
nationwide support hubs in the UK, giving those afflicted with a group of fellow sufferers to 
share ideas and information, but also partnering with locally engaged clinicians who will have 
a genuine desire to assess and diagnose the cause of smell loss and advise on any suitable 
treatment. International guidance is now available through the Position Paper on Olfactory 
Dysfunction10 and the partnership between patients and clinicians will help to move the cause 
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